0001022079-22-000102.txt : 20220525 0001022079-22-000102.hdr.sgml : 20220525 20220525163118 ACCESSION NUMBER: 0001022079-22-000102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220523 FILED AS OF DATE: 20220525 DATE AS OF CHANGE: 20220525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUSCKOWSKI STEPHEN H CENTRAL INDEX KEY: 0001142624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 22963336 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_165351065441914.xml FORM 4 X0306 4 2022-05-23 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001142624 RUSCKOWSKI STEPHEN H 500 PLAZA DRIVE SECAUCUS NJ 07094 1 1 0 0 Chairman, CEO and President Common Stock 2022-05-23 4 M 0 34898 103.57 A 369731 D Common Stock 2022-05-23 4 S 0 33898 140.124 D 335833 D Common Stock 2022-05-23 4 S 0 800 141.542 D 335033 D Common Stock 2022-05-23 4 S 0 200 142.255 D 334833 D Common Stock 2022-05-23 4 M 0 42568 86.63 A 377401 D Common Stock 2022-05-23 4 S 0 41268 140.119 D 336133 D Common Stock 2022-05-23 4 S 0 1000 141.509 D 335133 D Common Stock 2022-05-23 4 S 0 300 142.24 D 334833 D Common Stock 2022-05-24 4 M 0 126126 103.57 A 460959 D Common Stock 2022-05-24 4 S 0 126126 140.12 D 334833 D Common Stock 2022-05-24 4 M 0 156282 86.63 A 491115 D Common Stock 2022-05-24 4 S 0 156282 140.122 D 334833 D Non-Qualifed Stock Option (right to buy) 103.57 2022-05-23 4 M 0 34898 103.57 D 2028-02-19 Common Stock 34898.0 136163 D Non-Qualifed Stock Option (right to buy) 86.63 2022-05-23 4 M 0 42568 86.63 D 2029-02-18 Common Stock 42568.0 171136 D Non-Qualifed Stock Option (right to buy) 103.57 2022-05-24 4 M 0 126126 103.57 D 2028-02-19 Common Stock 126126.0 10037 D Non-Qualifed Stock Option (right to buy) 86.63 2022-05-24 4 M 0 156282 86.63 D 2029-02-18 Common Stock 156282.0 14854 D This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. This transaction was executed in multiple trades at prices ranging from $140.00 to $140.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $141.11 to $141.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $142.22 to $142.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $140.00 to $140.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $141.11 to $141.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $142.21 to $142.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $140.00 to $140.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $140.00 to $140.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The options vested in three annual installments beginning with the first on February 19, 2019, the second on February 19, 2020 and the final on February 19, 2021. The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Stephen H. Rusckowski 2022-05-25